Protein Kinase Inhibitors: all 15,278 studies that test it

Page 65 of 153. Open to participants first (2,556), then studies with results posted, then the rest; newest registration first within each.

• Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)CompletedNCT00569946Phase 2Results posted
• Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFRCompletedNCT00567359Phase 2Results posted
• Phase II Study of Vandetanib in Individuals With Kidney CancerCompletedNCT00566995Phase 2Results posted
• Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone MetastasisCompletedNCT00566618Phase 1/2Results posted
• Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XPCompletedNCT00565370Phase 1/2Results posted
• Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung CancerTerminatedNCT00564876Phase 2Results posted
• TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00563784Phase 2Results posted
• Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic LeukemiaCompletedNCT00563290Phase 2Results posted
• Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsCompletedNCT00561795Phase 2Results posted
• Dasatinib in Combination With Revlimid (and Dexamethasone)CompletedNCT00560391Phase 1Results posted
• Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple MyelomaTerminatedNCT00560352Phase 1Results posted
• Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive IodineCompletedNCT00559949Phase 2Results posted
• Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00559507Phase 2Results posted
• A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00558636Phase 3Results posted
• Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseCompletedNCT00558272Phase 2Results posted
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerCompletedNCT00558103Phase 2Results posted
• Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell CarcinomaTerminatedNCT00557830Phase 2Results posted
• Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00557193Phase 3Results posted
• A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556712Phase 3Results posted
• A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556322Phase 3Results posted
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaCompletedNCT00556049Phase 2Results posted
• An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.CompletedNCT00555906Phase 2Results posted
• Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric CancerCompletedNCT00555672Phase 1Results posted
• Imatinib Mesylate (Gleevec) in the Treatment of Systemic SclerosisCompletedNCT00555581Phase 2Results posted
• Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In SituCompletedNCT00555152Not applicableResults posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• Study Of Sunitinib With S-1 And Cisplatin For Gastric CancerCompletedNCT00553696Phase 1Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00553462Phase 2Results posted
• Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) StudyCompletedNCT00553358Phase 3Results posted
• Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By SurgeryCompletedNCT00553332Phase 2Results posted
• Trial Of PF-00299804 In Patients With Advanced Refractory Lung CancerCompletedNCT00553254Phase 2Results posted
• Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT00553150Phase 1/2Results posted
• Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting StentsCompletedNCT00552669Phase 4Results posted
• Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerCompletedNCT00551070Phase 2Results posted
• Dasatinib in Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00550615Phase 1/2Results posted
• Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00550537Phase 2Results posted
• A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid ArthritisCompletedNCT00550446Phase 2Results posted
• A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00550173Phase 2Results posted
• A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid ArthritisCompletedNCT00550043Phase 2Results posted
• Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00549848Phase 3Results posted
• Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung CancerTerminatedNCT00549328Phase 2Results posted
• Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell TransplantationTerminatedNCT00548717Phase 2Results posted
• Lapatinib and Trastuzumab With or Without Endocrine TherapyCompletedNCT00548184Phase 2Results posted
• PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And ErlotinibCompletedNCT00548093Phase 2Results posted
• Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00547105Phase 2Results posted
• Phase II Dasatinib Study in Advanced Breast CancerCompletedNCT00546104Phase 2Results posted
• Dasatinib in Treating Patients With Stage IV Pancreatic CancerTerminatedNCT00544908Phase 2Results posted
• Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma MultiformeCompletedNCT00544817Phase 2Results posted
• Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast CancerCompletedNCT00544167Not applicableResults posted
• Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)CompletedNCT00543387Phase 1Results posted
• Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)CompletedNCT00542971Phase 1/2Results posted
• A Study for Patients With Non-Hodgkin's LymphomasCompletedNCT00542919Phase 2Results posted
• Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeCompletedNCT00540722Phase 2Results posted
• Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by SurgeryTerminatedNCT00539617Phase 2Results posted
• Dasatinib in Polycythemia VeraTerminatedNCT00538980Phase 2Results posted
• Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + PlaceboTerminatedNCT00538681Phase 2Results posted
• Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCompletedNCT00537095Phase 2Results posted
• Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNCT00537056Not applicableResults posted
• Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast CancerTerminatedNCT00536939Phase 2Results posted
• Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma PatientsCompletedNCT00536575Phase 1/2Results posted
• Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00536107Phase 4Results posted
• Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas RecipientsCompletedNCT00533442Phase 2Results posted
• Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With ChemotherapyCompletedNCT00533429Phase 2Results posted
• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract CarcinomasTerminatedNCT00532441Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00531960Phase 2Results posted
• Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerCompletedNCT00530621Phase 2Results posted
• Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell CancerCompletedNCT00529802Phase 2Results posted
• Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) SubjectsCompletedNCT00529763Phase 2Results posted
• AZD0530 in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00528645Phase 2Results posted
• Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00527124Phase 2Results posted
• Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian CancerTerminatedNCT00526799Phase 1/2Results posted
• Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And LapatinibCompletedNCT00526669Phase 2Results posted
• Sunitinib in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00526656Phase 2Results posted
• Everolimus in Treating Patients With Newly Diagnosed Localized Prostate CancerTerminatedNCT00526591Phase 2Results posted
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or GliosarcomaCompletedNCT00525525Phase 2Results posted
• Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast CancerTerminatedNCT00525161Phase 2Results posted
• LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating MutationsCompletedNCT00525148Phase 2Results posted
• Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00524316Phase 2Results posted
• Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal CancerCompletedNCT00524121Phase 2Results posted
• Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second RemissionTerminatedNCT00522301Phase 2Results posted
• Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by SurgeryCompletedNCT00521001Phase 2Results posted
• Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2Results posted
• Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)TerminatedNCT00519090Phase 3Results posted
• Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and NeckCompletedNCT00519077Phase 2Results posted
• A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00518011Phase 2Results posted
• RAD001 in Advanced Hepatocellular CarcinomaCompletedNCT00516165Phase 1/2Results posted
• Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)TerminatedNCT00515086Phase 2Results posted
• BIBW 2992 (Afatinib) in Head & Neck CancerCompletedNCT00514943Phase 2Results posted
• Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose RegimenCompletedNCT00514514Phase 3Results posted
• Sunitinib in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00514137Phase 2Results posted
• Vandetanib to Treat Children and Adolescents With Medullary Thyroid CancerCompletedNCT00514046Phase 1/2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00513435Phase 2Results posted
• AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00513071Phase 2Results posted
• A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic SclerosisCompletedNCT00512902Phase 1/2Results posted
• Gleevec Study for Patients With Ovarian CancerCompletedNCT00510653Phase 2Results posted
• Sorafenib in Myelodysplastic SyndromeTerminatedNCT00510289Phase 2Results posted
• Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine TumorsCompletedNCT00510068Phase 3Results posted
• Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia MyelofibrosisCompletedNCT00509899Phase 1/2Results posted
• Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed GlioblastomaCompletedNCT00509821Phase 2Results posted

← Protein Kinase Inhibitors overview